SCHEMBL31020168

SCHEMBL31020168

Oc1ccc(CCNc2ccnc3cc(Cl)ccc23)cc1

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.70
CCR1 P32246 1/20 0.67
FERMT2 Q96AC1 4/20 0.64
GAA P10253 1/20 0.62
MAPT P10636 1/20 0.62
ATM Q13315 1/20 0.62
CCNC P24863 1/20 0.62
CDK8 P49336 1/20 0.62
NR4A2 P43354 1/20 0.59
HRH3 Q9Y5N1 1/20 0.59
PKM P14618 1/20 0.57
HTT P42858 2/20 0.57
KDM4E B2RXH2 1/20 0.57
LMNA P02545 1/20 0.57
HSD17B10 Q99714 1/20 0.57
NR2F2 P24468 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21855417 1.00 CYP1A2 (0.70) CYP1A2CCR1FERMT2GAAMAPT
SCHEMBL7500391 0.92 CYP1A2 (0.78) CYP1A2CCR1FERMT2CCNCCDK8
SCHEMBL7510312 0.87 CYP1A2 (0.70) CYP1A2CCR1FERMT2CCNCCDK8
SCHEMBL7503073 0.87 CCNC (0.81) CYP1A2CCR1FERMT2GAAMAPT
SCHEMBL21946633 0.85 HTR1A (0.70) CYP1A2CCR1FERMT2GAAMAPT
SCHEMBL7504559 0.85 CYP1A2 (0.70) CYP1A2CCR1FERMT2CCNCCDK8
SCHEMBL7502923 0.84 CCR1 (0.79) CYP1A2CCR1FERMT2NR4A2HRH3
SCHEMBL7501744 0.84 CYP1A2 (0.65) CYP1A2CCR1FERMT2CCNCCDK8
SCHEMBL8738060 0.83 CYP1A2 (1.00) CYP1A2CCR1FERMT2NR4A2PKM
SCHEMBL7498554 0.83 CCR1 (0.82) CYP1A2CCR1FERMT2NR4A2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3866802-B1 QUINONE REDUCTASE 2 INHIBITORS FOR USE AS NEUROPROTECTIVE AGENTS UNIV DUKE (US) 2024-08-21 EP claimed
CN-112823006-B Quinone reductase 2 inhibitors as neuroprotective agents 杜克大学 2024-09-17 CN disclosed